Guangzhou First People's Hospital

• Clinical study on the safety and efficacy of allogeneic human bone marrow mesenchymal stem cells in the treatment of sarcopenia-osteoporosis syndrome in the elderly

  Phase 1, Status unknown, 25 people, 1 Aug 2026

• NCT07176182

  Collaborator, Phase 2, Recruiting, 236 people, 16 Sept 2025

• NCT06810791

  Collaborator, Phase 3, Recruiting, 876 people, 6 Feb 2025

• NCT06763666

  Collaborator, Phase 4, Not yet recruiting, 172 people, 8 Jan 2025

• NCT06447701

  Collaborator, Phase 3, Not yet recruiting, 486 people, 7 Jun 2024

• NCT05453552

  Collaborator, Phase 2/3, Status unknown, 242 people, 12 Jul 2022

• NCT05449899

  Collaborator, Phase 2/3, Status unknown, 232 people, 8 Jul 2022

• NCT05404516

  Collaborator, Phase 2, Status unknown, 88 people, 3 Jun 2022

• NCT05313958

  Collaborator, Phase 2/3, Status unknown, 43 people, 6 Apr 2022

• NCT04713956

  Collaborator, Phase 2/3, Status unknown, 242 people, 19 Jan 2021

• NCT03804931

  Phase 2/3, Recruiting, 120 people, 15 Jan 2019

• NCT03733327

  Collaborator, Phase 2/3, Status unknown, 20 people, 7 Nov 2018

• NCT03613545

  Phase 2/3, Recruiting, 120 people, 3 Aug 2018

• NCT03596892

  Collaborator, Phase 2/3, Status unknown, 122 people, 24 Jul 2018

• NCT03530085

  Collaborator, Phase 2/3, Status unknown, 60 people, 21 May 2018

• NCT03385096

  Collaborator, Phase 2/3, Status unknown, 122 people, 28 Dec 2017

• NCT03229616

  Collaborator, Phase 2/3, Status unknown, 122 people, 25 Jul 2017

• NCT02838992

  Collaborator, Phase 4, Status unknown, 130 people, 20 Jul 2016

• NCT02671708

  Collaborator, Phase 2/3, Completed, 153 people, 2 Feb 2016

• NCT02670252

  Collaborator, Phase 3, Completed, 550 people, 1 Feb 2016

Sources: trialsearch.who.int